News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,355 Results
Type
Article (26442)
Company Profile (61)
Press Release (367850)
Multimedia
Podcasts (36)
Webinars (7)
Section
Business (104541)
Career Advice (464)
Deals (16908)
Drug Delivery (56)
Drug Development (47815)
Employer Resources (48)
FDA (12351)
Job Trends (8494)
News (186616)
Policy (19551)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1761)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26861)
ALS (95)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (161)
Approvals (12684)
Artificial intelligence (304)
Autoimmune disease (90)
Automation (8)
Bankruptcy (142)
Best Places to Work (6901)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (41)
Bladder cancer (124)
Brain cancer (37)
Breast cancer (414)
Cancer (3064)
Cardiovascular disease (267)
Career advice (424)
Career pathing (15)
CAR-T (135)
CDC (26)
Celiac Disease (2)
Cell therapy (367)
Cervical cancer (26)
Clinical research (42974)
Collaboration (849)
Compensation (272)
Complete response letters (17)
COVID-19 (1558)
CRISPR (35)
C-suite (485)
Cystic fibrosis (59)
Data (4223)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (318)
Diagnostics (3716)
Digital health (29)
Diversity (7)
Diversity, equity & inclusion (14)
Drug discovery (96)
Drug pricing (93)
Drug shortages (22)
Duchenne muscular dystrophy (124)
Earnings (38694)
Editorial (30)
Employer branding (6)
Employer resources (47)
Events (54326)
Executive appointments (586)
FDA (14626)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (754)
Gene editing (75)
Generative AI (20)
Gene therapy (259)
GLP-1 (558)
Government (3146)
Grass and pollen (4)
Guidances (230)
Healthcare (12236)
HIV (38)
Huntington's disease (21)
IgA nephropathy (50)
Immunology and inflammation (88)
Immuno-oncology (25)
Indications (67)
Infectious disease (1689)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (119)
Interviews (41)
IPO (7082)
IRA (23)
Job creations (1849)
Job search strategy (388)
JPM (19)
Kidney cancer (10)
Labor market (34)
Layoffs (196)
Leadership (8)
Legal (3659)
Liver cancer (66)
Longevity (7)
Lung cancer (482)
Lymphoma (249)
Machine learning (17)
Management (17)
Manufacturing (299)
MASH (105)
Medical device (13297)
Medtech (13342)
Mergers & acquisitions (10346)
Metabolic disorders (772)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (163)
Neuropsychiatric disorders (42)
Neuroscience (1695)
NextGen: Class of 2026 (3935)
Non-profit (2843)
Now hiring (33)
Obesity (329)
Opinion (97)
Ovarian cancer (119)
Pain (141)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (225)
Patient recruitment (349)
Peanut (42)
People (35666)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12346)
Phase 2 (18589)
Phase 3 (15277)
Pipeline (3031)
Policy (125)
Postmarket research (1671)
Preclinical (3816)
Press Release (19)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (178)
Rare diseases (426)
Real estate (2875)
Recruiting (18)
Regulatory (15692)
Reports (18)
Research institute (1654)
Resumes & cover letters (50)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (117)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2136)
Stomach cancer (11)
Supply chain (62)
Tariffs (28)
The Weekly (16)
Vaccines (505)
Venture capital (31)
Weight loss (226)
Women's health (54)
Worklife (4)
Date
Last 7 days (304)
Last 30 days (1102)
Last 365 days (16179)
2026 (1474)
2025 (16520)
2024 (19894)
2023 (22762)
2022 (30708)
2021 (33016)
2020 (32224)
2019 (28453)
2018 (21844)
2017 (18918)
2016 (18122)
2015 (21225)
2014 (16039)
2013 (13253)
2012 (14362)
2011 (14664)
2010 (13219)
Location
Africa (370)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25520)
Australia (4032)
California (5587)
Canada (1903)
China (787)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49937)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (578)
India (34)
Indiana (377)
Iowa (11)
Japan (316)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3748)
Michigan (150)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1925)
New Mexico (10)
New York (1562)
North Carolina (811)
North Dakota (4)
Northern California (2660)
Ohio (212)
Oklahoma (8)
Oregon (29)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (524)
South Carolina (59)
Southern California (2235)
Tennessee (124)
Texas (1017)
United States (21634)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,355 Results for "tides medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LUNGevity and Rising Tide Foundation Issue RFA Tackling Lung Cancer’s Toughest Challenges: Drug Resistance and Cancer Recurrence
January 16, 2026
·
5 min read
Biotech Bay
Vivani Medical to Present at TIDES Conference 2024
Vivani Medical, Inc. today announced that it will present at the TIDES Conference 2024 at 4:30 p.m. ET at the Hynes Convention Center in Boston on Friday, May 17.
May 9, 2024
·
4 min read
Press Releases
EnPlusOne Biosciences To Present New Data at TIDES USA
May 15, 2025
·
2 min read
Press Releases
CytoSorbents To Host Global Webinar on “Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb” in Recognition of World Sepsis Day
September 8, 2025
·
8 min read
Press Releases
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
May 12, 2025
·
9 min read
Press Releases
Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities
June 5, 2025
·
1 min read
Press Releases
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
May 7, 2025
·
6 min read
Press Releases
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
May 22, 2025
·
9 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024
YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan.
March 13, 2024
·
1 min read
1 of 39,436
Next
